Author

J. García-Revillo

Instituto Maimónides de Investigación Biomédica de Córdoba

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Adela García‐MartíniD· 1 shared Ana RodrígueziD· 1 shared Antonella Medeot· 1 shared Antonio Chacón· 1 shared Carmen M. NavarreteiD· 1 shared Eduardo MuñóziD· 1 shared Francisco J. Ponce‐Díaz· 1 shared Ígnacio MuñoziD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Adela García‐MartínORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Etrinabdione (VCE-004.8), a B55a activator, promotes angiogenesis and arteriogenesis in critical limb ischemia.

Adela García‐Martín, María E. Prados, Isabel Lastres-Cubillo, Francisco J. Ponce‐Díaz, Laura Cerero‐Tejero, Martín Garrido‐Rodríguez, Carmen M. Navarrete, Rafael Pineda, Ana Rodríguez, Ígnacio Muñoz, Javier Moya, Antonella Medeot, José A. Moreno, Antonio Chacón, J. García-Revillo, Eduardo Muñóz

This study shows that Etrinabdione (VCE-004.8) activates B55 to promote angiogenesis and arteriogenesis in critical limb ischemia by enhancing HIF-1 and reducing fibrosis.

Journal of Translational Medicine · Nov 6, 2024Peer-reviewedPharmacology & Toxicology